Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Suppliers list
|
Company Name: |
Shanghai Kewel Chemical Co., Ltd.
|
Tel: |
021-64609169 18901607656 |
Email: |
greensnown@163.com |
Products Intro: |
Product Name:Rapamycin Impurity 37 CAS:151945-42-5 Purity:95+ HPLC; Package:10mg;25mg;50mg;100mg
|
Company Name: |
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd
|
Tel: |
18162595016; 18162595016 |
Email: |
3287908757@qq.com |
Products Intro: |
Product Name:1-Pyrrolidinepropanol,α-cyclohexyl-α-(4-methoxyphenyl)-β-phenyl- CAS:151945-42-5 Purity:95%+HPLC Package:10mg;25mg;50mg;100mg;200mg
|
Company Name: |
guoyungurui
|
Tel: |
18502726233 |
Email: |
2012558459@qq.com |
Products Intro: |
Product Name:Rapamycin Impurity 37 CAS:151945-42-5
|
|
| Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Basic information |
Product Name: | Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- | Synonyms: | Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]-;Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,...;1-Pyrrolidinepropanol,α-cyclohexyl-α-(4-methoxyphenyl)-β-phenyl-;Rapamycin Impurity 37 | CAS: | 151945-42-5 | MF: | C51H79NO13 | MW: | 914.17 | EINECS: | | Product Categories: | | Mol File: | Mol File | |
| Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Chemical Properties |
Boiling point | 992.2±65.0 °C(Predicted) | density | 1.19±0.1 g/cm3(Predicted) | pka | 10.46±0.20(Predicted) |
| Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Usage And Synthesis |
| Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Preparation Products And Raw materials |
|